Biolase, inc (BIOL)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash Flows from Operating Activities:
Net loss

-6,006

-3,587

-5,469

-3,899

-4,900

-6,919

-4,665

-4,911

-5,021

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-4,289

-4,108

-

-3,146

-3,533

-4,265

-2,458

-5,343

-7,041

-5,436

-4,105

-3,495

-6,439

-4,887

-2,234

-4,049

-2,568

-2,631

1,041

-548

-1,877

-1,672

-2,030

-953

-753

-750

Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization

177

228

225

271

258

233

203

245

264

316

310

287

290

272

288

276

212

291

265

166

158

167

177

177

175

162

141

153

145

140

126

122

125

133

151

183

228

Loss (gain) on disposal of property, plant, and equipment, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-3

1

-

-

-

-

-

-

-

-

-44

16

-1

-7

Provision for bad debts

987

452

1,132

92

19

153

86

30

200

-14

-1

45

10

-46

13

-70

-15

-

-

-

-

499

42

486

268

-

-

-

-

48

-122

299

16

-

-

-

-

Provision for sales allowance

-

-

-

-

-

-

-

-

4

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for bad debts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

102

-11

-

-

-

-

-

-

-

-

Provision for inventory excess and obsolescence

-

-

-

-

-

-

-

-

-

275

123

0

225

-

-

-

-

-

-

-

-

324

0

0

261

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discounts on lines of credit

46

37

-6

71

38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

80

120

-

-

18

18

-

-

-

-

-

-

-

-

Provision for bad debts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10

Amortization of discounts on term loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

78

Amortization of debt issuance costs

50

58

44

37

49

83

18

18

7

-

-

-

-

-

-

-

-

-

-

-

-

0

0

71

57

45

71

43

38

-

-

-

-

0

0

0

99

Stock-based compensation

719

768

770

447

757

906

604

557

701

603

464

761

379

597

688

946

834

-

-

-

-

-

-

276

310

-

491

380

368

320

357

340

583

528

324

456

220

Other equity instruments compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64

-

0

-2

25

47

16

114

96

Other non-cash compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-62

-61

-63

-63

-62

-62

-63

-63

-62

-62

-437

311

-63

-61

(Recovery) provision for bad debts, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

228

53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

935

700

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-32

13

-1

0

-5

-28

-1

0

2

-739

15

15

15

15

15

15

15

15

15

16

15

15

15

15

15

31

10

36

-107

-

-

-

-

55

0

-1

-1

Earned interest income, net

-

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earned interest income

-

-

-

-

-

-

-

0

1

-

10

10

9

18

19

17

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of patent litigation settlement liability

-

-

-

-

-190

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Incurred but unpaid interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-3,024

738

-130

-1,913

650

-133

1,087

690

-186

389

-107

619

-564

-219

-1,105

842

1,126

-448

-531

171

860

239

2,709

-1,473

-2,301

344

-496

935

-1,047

1,619

611

892

100

10,412

-7,856

441

2,645

Inventory

1,197

-129

-797

311

-225

-1,057

-585

666

1,103

-1,333

-980

499

1,395

630

2,267

-909

1

-906

439

508

664

1,033

-51

-41

774

-235

254

638

779

272

500

363

-975

7,670

-4,114

969

191

Prepaid expenses and other current assets

142

572

-367

-181

-463

965

-835

-125

20

506

-62

-287

-146

609

-237

-482

31

-212

-108

-292

677

2

8

13

-2

3

0

-36

-23

149

124

-117

-606

494

544

-274

-212

Customer deposits

-

-

-

-

-

-

-

-

-

-

-

31

-7

-

12

-65

46

-20

9

-80

64

0

-29

-10

-135

111

0

-104

-304

330

80

152

-145

-14

-738

-2,036

-2,923

Accounts payable and accrued liabilities

-1,541

-1,999

563

-206

-1,514

-1,438

1,126

1,614

460

-1,875

-529

-1,788

-885

1,218

2,095

180

-155

-2,280

403

2,327

-1,090

-1,972

-896

3,711

-392

-1,239

-250

1,149

-659

1,246

551

-1,187

-957

1,871

1,125

803

431

Deferred revenue

-219

78

-1

0

37

209

48

23

-441

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-6

-347

-

-148

216

-270

142

-96

222

535

63

-803

-41

-190

279

60

-7

-96

234

319

626

-111

224

-288

139

4

Net cash and cash equivalents used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-5,122

-

-1,178

-1,503

-4,772

-2,818

-3,915

-3,637

-7,402

-5,927

-7,372

-105

-2,797

-

-

-2,273

-2,822

-

-

-

-

-

-

-

-

Net cash and cash equivalents used in operating activities

-4,134

-4,672

-1,447

-1,593

-5,034

-3,557

-2,245

-3,583

-4,762

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-253

-2,681

-593

-2,018

-4,199

-2,039

-5,064

Cash Flows from Investing Activities:
Purchases of property, plant, and equipment

9

69

13

117

8

448

0

8

102

-78

188

429

208

359

553

159

343

550

820

205

228

4

71

37

86

211

133

192

139

93

258

191

266

134

137

139

18

Proceeds from disposal of property, plant, and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

-

-

-

-

-

-

-

-

-

-

-

-

Net cash and cash equivalents used in investing activities

-9

-69

-13

-117

-8

-448

36

-8

-102

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-134

-191

-266

-134

-137

-139

-18

Cash Flows from Financing Activities:
Purchased other intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

10

-

-

-

-

-

-

-

-

Net cash and cash equivalents used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-208

-

-553

-159

-343

-550

-795

-205

-228

-4

-71

-37

-85

-

-

-192

-149

-

-

-

-

-

-

-

-

Principal payments under capital lease obligation

-

-

-

-

-

0

0

0

46

18

42

43

43

28

57

43

43

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings under lines of credit

-

-

-

-

-

373

1,500

0

1,823

-

-

-

-

-

-

-

-

-

-

-

-

0

1,300

8,005

7,570

7,800

7,750

11,200

8,350

-

-

-

-

-

-

-

-

Payments under lines of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

4,604

7,579

9,325

8,701

8,208

8,469

6,726

-

-

-

-

-

-

-

-

Payments under term loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,700

Payments of debt issuance costs

-

-

-

-

-

971

0

13

74

-

-

-

-

-

-

-

-

-

-

-

-

0

0

35

10

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from equity offerings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,816

11,509

0

4,793

-

-

-

-

-

-

-

-

-14

-88

10,276

7,049

Payments of equity offering costs

117

-

-

-

-

-

0

57

81

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

0

0

1

3

1

0

0

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposit on capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

42

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76

-

-

-

277

-

-

-

594

Proceeds from exercise of stock options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

44

-

54

8

248

-

-

-

-

-

-

-

-

-

-

-

-

Net cash and cash equivalents provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-43

-

9,485

-43

-43

-83

-24

0

2

34,818

8,259

399

3,276

-

-

3,352

1,700

-

-

-

-

-

-

-

-

Net cash and cash equivalents (used in) provided by financing activities

-117

8,305

-50

2,463

3

10,004

1,500

-1,893

1,624

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43

1,791

277

-246

44

10,646

4,943

Effect of exchange rate changes

-18

134

-119

11

-49

-83

3

-100

74

21

79

137

25

-124

19

-45

86

-44

6

25

-193

-86

-140

-9

1

17

72

-15

-43

44

32

-84

47

-52

-85

34

77

Decrease in cash, cash equivalents and restricted cash

-4,278

3,698

-1,629

764

-5,088

5,916

-706

-5,584

-3,166

7,191

-3,462

4,340

-5,348

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,773

-1,750

-5,072

-3,495

-4,728

-3,817

-7,821

28,801

676

248

395

-2,711

2,050

872

-1,314

1,248

-312

-1,165

-535

-2,450

-4,377

8,502

-62

Supplemental cash flow disclosure:
Cash paid for interest

485

469

484

401

430

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

1

-

1

1

1

-

-

-

-

5

42

34

67

55

84

50

31

43

35

7

3

-1

2

6

73

Cash paid for income taxes

28

16

7

-19

31

13

16

-9

24

-2

29

130

7

10

18

15

33

4

9

7

37

7

11

29

5

-4

2

4

45

11

22

8

21

36

0

0

8

Cash paid for operating leases

192

-

-

-

189

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental cash flow disclosure - Non-cash investing and financing activities
Assets acquired under capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-27

22

383

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash accrual for capital expenditures

7

14

-13

-7

24

-

-

-

4

42

-98

-16

174

137

12

32

70

346

236

534

21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash right-of-use assets obtained in exchange for lease obligation

-

-

0

0

824

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-